The Online Investor
Healthcare M&A image Healthcare M&A » By The Online Investor Staff, updated Thu., Aug. 6, 2:29 PM Recent mergers and acquisitions in the Healthcare M&A category.

Slide #17. Prestige Brands Holdings, Inc. Hydralyte

Acquirer: Prestige Brands Holdings, Inc. (NYSE:PBH)
Acquiree: Hydralyte
Details: Prestige Brands Holdings, Inc. (NYSE:PBH) ("Prestige") today announced that it has closed the previously announced acquisition of Hydralyte from the Hydration Pharmaceuticals Trust of Victoria, Australia. Hydralyte is the leading over-the-counter oral rehydration brand in Australia, and will be marketed and sold through Care Pharmaceuticals ("Care"), Prestige's subsidiary in Australia.

Prestige Consumer Healthcare is a holding company. Through its subsidiaries, Co. develops, manufactures, markets, sells and distributes over-the-counter (OTC) healthcare products to mass merchandisers and drug, food, dollar, convenience, club and e-commerce stores in North America and in Australia and certain other international markets. Co.'s portfolio of OTC Healthcare products includes, among others, DenTek oral care products, Monistat women's health products, Nix lice/parasite treatment products, Chloraseptic sore throat liquids, Clear Eyes eye and ear care products, Compound W wart removal, Luden's throat drops, BC and Goody's pain relievers and Debrox earwax remover.

PBH SEC Filing Email Alerts Service

Open the PBH Page at The Online Investor »

Company Name: 
Prestige Consumer Healthcare Inc
Stock buyback: 
PBH buyback
Drugs & Pharmaceuticals
Number of ETFs Holding PBH: 
Total Market Value Held by ETFs: 
Total Market Capitalization: 
% of Market Cap. Held by ETFs: 

Open the PBH Page at The Online Investor (in a new window) »

Quotes delayed 20 minutes

Buy (3.00 out of 4)
36th percentile
(ranked lower than approx. 64% of all stocks covered)
Based on Zacks ABR data;
powered by Xignite

Healthcare M&A - Slide 17 of 100 Page |

Copyright © 1998 - 2020, All Rights Reserved
Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes; data powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.